These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

5401 related items for PubMed ID: 3621452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma.
    Rosenblum MG, Murray JL, Haynie TP, Glenn HJ, Jahns MF, Benjamin RS, Frincke JM, Carlo DJ, Hersh EM.
    Cancer Res; 1985 May; 45(5):2382-6. PubMed ID: 3986780
    [Abstract] [Full Text] [Related]

  • 3. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
    Murray JL, Rosenblum MG, Lamki L, Glenn HJ, Krizan Z, Hersh EM, Plager CE, Bartholomew RM, Unger MW, Carlo DJ.
    J Nucl Med; 1987 Jan; 28(1):25-33. PubMed ID: 3794809
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Kinetic model for the biodistribution of an 111In-labeled monoclonal antibody in humans.
    Eger RR, Covell DG, Carrasquillo JA, Abrams PG, Foon KA, Reynolds JC, Schroff RW, Morgan AC, Larson SM, Weinstein JN.
    Cancer Res; 1987 Jun 15; 47(12):3328-36. PubMed ID: 3581071
    [Abstract] [Full Text] [Related]

  • 11. A preliminary pharmacokinetic study of 111In-labeled 260F9 anti-(breast cancer) antibody in patients.
    Griffin TW, Bokhari F, Collins J, Stochl M, Bernier M, Gionet M, Siebecker D, Wertheimer M, Giroves ES, Greenfield L.
    Cancer Immunol Immunother; 1989 Jun 15; 29(1):43-50. PubMed ID: 2706639
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY, Chu DZ, Yamauchi D, Odom-Maryon TL, Williams LE, Liu A, Esteban JM, Wu AM, Primus FJ, Beatty JD, Shively JE, Raubitschek AA.
    J Nucl Med; 1998 Dec 15; 39(12):2097-104. PubMed ID: 9867150
    [Abstract] [Full Text] [Related]

  • 14. Interferon-induced changes in pharmacokinetics and tumor uptake of 111In-labeled antimelanoma antibody 96.5 in melanoma patients.
    Rosenblum MG, Lamki LM, Murray JL, Carlo DJ, Gutterman JU.
    J Natl Cancer Inst; 1988 Apr 06; 80(3):160-5. PubMed ID: 3346909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. An antimelanoma immunotoxin containing recombinant human tumor necrosis factor: tissue disposition, pharmacokinetic, and therapeutic studies in xenograft models.
    Rosenblum MG, Cheung L, Mujoo K, Murray JL.
    Cancer Immunol Immunother; 1995 May 06; 40(5):322-8. PubMed ID: 7600565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 271.